Vertex Pharmaceuticals Reports Q3 2026 Financial Results
Vertex Pharmaceuticals has filed its Q3 2026 report, detailing significant financial metrics and ongoing projects in the pharmaceutical sector.
Transcat Inc. reports quarterly results, shows industry strength
Transcat Inc. has released its quarterly report, showcasing its performance in the measurement instruments sector and highlighting growth potential.
Sotera Health reports Q3 results, outlines future strategies
Sotera Health Co releases its Q3 financial results, detailing growth strategies and operational updates that impact the health services industry.
Bilibili schedules board meeting for Q3 2026 results approval
Bilibili Inc. announces board meeting on November 24, 2026, to approve Q3 2026 financial results, highlighting its commitment to transparency.
Arvinas reports Q3 results with updates on collaborations
Arvinas, Inc. releases its Q3 2026 report, highlighting financial performance and collaborations with Pfizer and Rigel Pharmaceuticals.
Nurix Therapeutics announces Sanofi halting SAR448272 trial
Nurix Therapeutics faces a setback as Sanofi discontinues its SAR448272 clinical trial, impacting future milestone payments and collaboration strategy.
Manitowoc Company reports Q3 2026 earnings results
Manitowoc Company announces its Q3 2026 earnings, highlighting key financial metrics and implications for the construction machinery industry.
Transcat Reports Strong Q2 Results with Revenue Growth
Transcat Inc. announces strong Q2 fiscal 2027 results, showcasing significant revenue growth and margin expansion, indicating robust performance in the testing instruments industry.
Denali Therapeutics Reports Strong Q3 2026 Financial Results
Denali Therapeutics Inc. announces robust Q3 2026 results, driven by AVLAYAH revenue growth and positive market response, signaling strong industry momentum.
Axos Financial unveils new investor presentation strategy
Axos Financial, Inc. announces a new investor presentation, showcasing its strategies and performance metrics, effective November 4, 2026.
Gladstone Commercial reports Q3 results with revenue decline
Gladstone Commercial Corp announces a decrease in total operating revenue for Q3 2026, reflecting ongoing challenges in the real estate sector.
Curaleaf Reports Record Third Quarter Revenue and Profitability
Curaleaf Holdings, Inc. announces impressive third-quarter results with record revenue of $353 million, demonstrating strong growth in the medicinal cannabis sector.
Mirum Pharmaceuticals announces Q3 results, raises sales guidance
Mirum Pharmaceuticals reports strong Q3 2026 results, raising sales guidance and highlighting FDA approvals, signaling growth in the pharmaceutical sector.
Avis Budget Group Reports Strong Q3 Results Amid Challenges
Avis Budget Group announces third-quarter results with $3.4 billion in revenue and $199 million in net income, showcasing resilience in the auto rental industry.
Ardelyx Reports Strong Q3 Results with $125.5M Revenue
Ardelyx, Inc. announces Q3 2026 financial results, reporting $125.5 million in revenue, driven by strong sales of IBSRELA and XPHOZAH.
Skyworks Solutions Reports Q4 and Fiscal Year 2026 Results
Skyworks Solutions, Inc. announces its fourth-quarter and fiscal year 2026 results, highlighting revenue growth and strategic integration with Qorvo.
Parker-Hannifin shareholders approve new directors, exec pay
Parker-Hannifin Corp's shareholders approve new directors and executive compensation at the annual meeting, signaling strong governance practices.
Booking Holdings reports financial results, highlights changes
Booking Holdings Inc. shares its latest financial results, impacting the transportation services industry and prompting competitors to reassess strategies.
Financial Security Advisor reveals $598.9M in holdings
Financial Security Advisor, Inc. discloses $598.9 million in investment holdings in its latest 13F filing, focusing on ETFs and major tech stocks.
AuguStar Variable Account A Announces Portfolio Reorganizations
AuguStar Variable Account A has approved three reorganizations affecting its variable annuity contracts and life insurance policies, streamlining operations.